Riboflavin as migraine prophylaxis in adolescents

  • Athaillah Athaillah Department of Child Health, University of North Sumatera Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Yazid Dimyati Department of Child Health, University of North Sumatera Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Johannes H. Saing Department of Child Health, University of North Sumatera Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Bistok Saing Department of Child Health, University of North Sumatera Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Hakimi Hakimi Department of Child Health, University of North Sumatera Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Aznan Lelo Department of Phannacology, University of North Sumatera Medical School/H. Adam Malik Hospital, Medan, North Sumatera
DOI: https://doi.org/10.14238/pi52.3.2012.132-7
Keywords: riboflavin, preventive, migraine, adolescents

Abstract

Background Migraine is a cause of recurrent headaches in
children. Riboflavin has been sho\Vll to be efficacious in preventing
migraine in adults. However, there has been little research on its
use in children and adolescents.
Objective To assess the effectiveness of riboflavin for migraine
prevention in adolescents.
Methods We conducted a randomized, doubleô€…blind, controlled
trial in the Islamic Centre of the Musthafav.iyah Mandailing Natal
District, North Sumatera, from May to July 2010. Adolescents
\\lith migraines, as defined criteria, were included. Subjects were divided into two groups,
receiving either 400 mg of riboflavin or placebo for 3 months.
Headache frequency was measured in headache days per month,
headache duration was measured in hours, and functional
disability was measured using the Pediatric Migraine Disability
Assessment Scale (PedMIDAS). Migraines were assessed before,
during and after intervention. Student's tô€…test was used for
statistical analysis.
Results A total of 98 patients, ranging from 12 to 19 years in
age (mean age 14.0 years) were enrolled. We found a significant
reduction in headache frequency in the second and third months.
Headache duration also differed significantly third months (P=0.012 and P=O.OOl, respectively). Riboflavin
decreased disability, as indicated by lower PedMIDAS scores in
the riboflavin group compared to the placebo group (26.1 and
34.3, respectively, P= 0.001).
Conclusion Riboflavin effectively decreased migraine frequency,
duration and disability in adolescents. [Paediatr Indones.
2012;52:132-7].

References

1. Haslam RH. Headache. In: Behrman RE, Kliegman RM,
Jenson HB, editors. Nelson textbook of pediatrics. 17th ed.
Philadelphia, W B Saunders; 2004. p. 2012A.
2. Lazuardi S. Nyeri kepala pada anak dan remaja. In:
Soetomenggolo TS, Ismael S, editors. Buku ajar neurologi
anak. 2nd ed. Jakarta, Balai Penerhit IDA!; 2000. p. 7S-S6.
3. Lazuardi S. Nyeri kepala pada anak dan remaja. In:
Pusponegoro HD, Passat J, Mangunatmadja I, Widodo DP,
Soetomenggolo TS, Ismael S, editors. Neurologi anak dalam
praktek sehari-hari (N askah lengkap PKB IKA XXXIV).
Jakarta, Balai Penerhit FK UI; 1995. p. IS9-206.
4. Weiss HD. Headache and facial pain. In: Johnson RT, Griffin
Jw, McArthur JC, editors. Current therapy in neurologic
disease. 7th ed. St. Louis: Mosby Inc; 2002. p. 81􀁨6.
5. Lewis DW, Diamond S, Scott D, Jones V. Prophylactic
treatment of pediatric migraine. Headache. 2004;44:
230-7.
6. Snow V, Weiss K, Wall EM, Mottur􀁨Pilson C. Pharmacologic
management of acute attacks of migraine and prevention of
migraine headache. Ann Intern Med. 2002;137:840􀁨9.
7. Modi S, Lowder DM. Medications for migraine prophylaxis.
Am Fam Physic. 2006;73m-S.
S. Chawla J, Malapira A.M igraine headache.c 2006 [cited 2011
January]. Available from: http://tilWw.emedicine.com/neuro/
wpic218.htm
9. Pakalnis A. New avenues in treatment of paediatric migraine:
a review of the literature. Fam Practice. 2001; 18: 10 1􀁨6.
10. Breen C, Crowe A, Roelfsema HJ, Saluja IS, Guenter D.
High􀁨dose riboflavin for prophylaxis of migraine. Can Fam
Physic. 2003;49,1291-3.
11. Maclennan SC, Wade FM, Forrest KM, Rtanayake
PD, Fargan E, Antony J, High􀁨dose riboflavin for
migraine prophylaxis in children: a double􀁨blind,
ramdomized, placebo􀁨controlled trial. J Child Neurol.
200S;23,1300A.
12. Bland SE. Pediatric migraine recognition management. J
Pharm Soc Wisconsin. 2002;2:41A.
13.
14.
15.
16.
17.
IS.
19.
20.
21.
22.
23.
24.
25.
26.
Dowson AJ, Lipscombe S, Carter F, Bradford S, Bundy M,
Rees T. Managing children and adolescents with migraine
and other headache: scientific and clinical aspects. Headache
Care. 2005;2,193-207.
VisudtibhanA.M igraine in Thai children: prevalence in junior
high school students. J Child Neurol. 2007;22,117-20.
Kundu NC, Ahmad C, Migraine management in children􀁨
review of strategies and recommendations. J Bangladesh Coll
Phys Surg. 2007;25m-S5.
Rossi LN, Continovis I, Menegazzo L, Brunelli G, Bossi A,
Macchi M. Classification criteria and distinction between
migraine and tension􀁨type headache in children. Dev Med
Child Neurol. 2001;43A5-51.
Hershey AD, Powers SW, Vockell B, LeCates S, Kabbouche
MA, Maynard M K . PedMIDAS development of a
questionnaire to assess disability of migraines in children.
Neurology. 2001 ;57 ,2034-9.
Anttila P, Metsahonkala L, Sillanpaa M. Long􀁨term trends
in the incidence of headache in Finnish school children.
Pediatric. 2006;117,1197-201.
Goadsby P J . Recent advances in the diagnosis and
management of migraine. Br Med J.2 006;332:25􀁨9.
Boehnke C, Reuter U, Flach U, Hofer SS, Einhupl KM,
Arnold G. High􀁨dose riboflavin treatment is efficacious in
migraine prophylaxis: an open study in a tertiary care centre.
Eur J Neurol. 2004;l1A75-7.
Rios J, Passe MM. Evidenced􀁨based use of botanicals,
minerals, and vitamins in the prophylactic treatment of
migraines. J Am Acad Nurse Pract. 2004;16:251􀁨6.
Fischer M, Bacher A. Biosynthesis of vitamin B2: structure
and mechanism of riboflavin synthase. Arch Biochem
Biophys.200S;474,252-65.
Condo M, Posar A, Arbizzani A, Parmeggiani A. Riboflavin
prophylaxis in pediatric and adolescent migraine. J Headache
pain. 2009;10,361-5
Sandor PS, Afra J, Ambrossini A, Schoenen J. Prophylactic
treatment of migraine with beta blockers and riboflavin:
differential effects on the intensity dependence of auditory
evoked cortical potentials. Headache. 2000;40:30􀁨5.
Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high dose
riboflavin in migraine prophylaxis: a randomized, controlled
trial. Neurology. 1995;50A66-70.
Hershey AD, Powers SW, Vockell A􀁨LB, LeCates SL, Segers
A, Kabbouche MA. Development of a patient􀁨based grading
scale for PedMIDAS. Cephalalgia. 2004;24,S44-9.
Published
2012-06-30
How to Cite
1.
Athaillah A, Dimyati Y, Saing JH, Saing B, Hakimi H, Lelo A. Riboflavin as migraine prophylaxis in adolescents. PI [Internet]. 30Jun.2012 [cited 22Nov.2024];52(3):132-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/379
Issue
Vol 52 No 3 (2012): May 2012
Section
Articles

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Received 2016-08-30
Accepted 2016-08-30
Published 2012-06-30